Literature DB >> 30599817

Pre-meal and postprandial lipaemia in subjects with the metabolic syndrome: effects of timing and protein quality (randomised crossover trial).

Ann Bjørnshave1, Trine Nygaard Johansen1, Bashar Amer2, Trine Kastrup Dalsgaard2, Jens Juul Holst3, Kjeld Hermansen1.   

Abstract

Non-fasting TAG - postprandial lipaemia (PPL) - are to a higher degree associated with cardiovascular risk compared with fasting TAG. Dietary protein, especially whey proteins (WP), may lower PPL. We hypothesised that a WP pre-meal (17·6 g protein) consumed 15 v. 30 min before a fat-rich meal reduces the PPL response in subjects with the metabolic syndrome (MetS) and that a WP pre-meal has more potent effects than casein and gluten pre-meals. A total of sixteen subjects with the MetS completed an acute, randomised, crossover trial. WP pre-meals were consumed 15 and 30 min, and casein and gluten 15 min before a fat-rich meal. Blood samples were drawn 360 min postprandially to determine metabolite and hormone responses, S-paracetamol (for assessment of gastric emptying) and amino acids. Insulin and glucagon responses were affected by both timing and protein type (for all P <0·01), with significantly higher concentrations for WP given at -15 min than WP at -30 min and higher responses compared with gluten for the first 30 min after pre-meal consumption (for all P <0·05). The PPL responses changed neither by timing nor by protein type. Glucose-dependent insulinotropic peptide but not glucagon-like peptide 1 responses differed between the three protein types. S-paracetamol concentration was higher for WP (-30 min) than for WP (-15 min) 15 min after the main meal (P = 0·028), and higher for casein and gluten than for WP at time point 30 min (for all P <0·05). In conclusion, the PPL response was not changed by ingestion of a 17·6 g protein pre-meal, whereas both timing and protein quality affected hormone secretion (insulin and glucagon).

Entities:  

Keywords:  AA amino acid; BCAA branched-chain amino acid; E% energy percentage; GIP glucose-dependent insulinotropic peptide; GLP-1 glucagon-like peptide 1; PPL postprandial lipaemia; WP whey protein; iAUC incremental AUC; Metabolic syndrome; Postprandial lipaemia; Pre-meal lipaemia; Protein quality; Timing; Whey proteins

Year:  2019        PMID: 30599817     DOI: 10.1017/S0007114518003264

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  5 in total

1.  Effect of Different Nutritional Supplements on Glucose Response of Complete Meals in Two Crossover Studies.

Authors:  Nele Gheldof; Celia Francey; Andreas Rytz; Léonie Egli; Frederik Delodder; Lionel Bovetto; Nathalie Piccardi; Christian Darimont
Journal:  Nutrients       Date:  2022-06-28       Impact factor: 6.706

2.  Pre-meal protein intake alters postprandial plasma metabolome in subjects with metabolic syndrome.

Authors:  Ceyda Tugba Pekmez; Ann Bjørnshave; Giulia Pratico; Kjeld Hermansen; Lars Ove Dragsted
Journal:  Eur J Nutr       Date:  2019-07-06       Impact factor: 5.614

Review 3.  Effect of Nutrient and Micronutrient Intake on Chylomicron Production and Postprandial Lipemia.

Authors:  Charles Desmarchelier; Patrick Borel; Denis Lairon; Marie Maraninchi; René Valéro
Journal:  Nutrients       Date:  2019-06-08       Impact factor: 5.717

4.  Whey protein consumption following fasted exercise reduces early postprandial glycaemia in centrally obese males: a randomised controlled trial.

Authors:  Dean M Allerton; Daniel J West; Emma J Stevenson
Journal:  Eur J Nutr       Date:  2020-06-22       Impact factor: 5.614

Review 5.  The Clinical Application of Mealtime Whey Protein for the Treatment of Postprandial Hyperglycaemia for People With Type 2 Diabetes: A Long Whey to Go.

Authors:  Kieran Smith; Kelly A Bowden Davies; Emma J Stevenson; Daniel J West
Journal:  Front Nutr       Date:  2020-10-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.